Exchange: OTC·Updated 09:34 AM EST

VXLLF Vaxil Bio Ltd

$0.0271
$0.0526
(66.00%)
Today
Mkt Cap$108,000.00
Vol1,995.00

About VXLLF

Vaxil Bio Ltd. is a biotechnology company engaged in the development of signal peptide-based immunotherapies for the treatment of cancer and infectious diseases. Its pipeline consists of ImMucin, SPmAb2, SPmAb6, and MTbuVax. The company was founded on July 26, 2006 and is headquartered in Toronto, Canada.
50

Neutral Sentiment

How do you feel about VXLLF?

Advertisement|Remove ads.